Orange Book product · Brand (NDA)
LIBRIUM
CHLORDIAZEPOXIDE HYDROCHLORIDE
At a glance
Approved Prior to Jan 1, 1982
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
No patent or exclusivity dates are listed for this product.
Pharmaceutical detail
Active ingredient
CHLORDIAZEPOXIDE HYDROCHLORIDE
Strength
100MG/AMP
Dosage form
INJECTABLE
Route
INJECTION
TE code
Not listed
Application
NDA 012301
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a brand (NDA) product. Other products sharing this active ingredient are listed below.
- 1988CHLORDIAZEPOXIDE HYDROCHLORIDEGeneric (ANDA)
ANDA 089533 · PIONEER PHARMS
- 1988CHLORDIAZEPOXIDE HYDROCHLORIDEGeneric (ANDA)
ANDA 089558 · PIONEER PHARMS
- 1985CHLORDIAZEPOXIDE HYDROCHLORIDEGeneric (ANDA)
ANDA 088987 · SUPERPHARM
- 1982CHLORDIAZEPOXIDE HYDROCHLORIDEGeneric (ANDA)
ANDA 087525 · ASCOT
- 1982CHLORDIAZEPOXIDE HYDROCHLORIDEGeneric (ANDA)
ANDA 087524 · ASCOT
- 1982CHLORDIAZEPOXIDE HYDROCHLORIDEGeneric (ANDA)
ANDA 087512 · ASCOT
- —A-POXIDEGeneric (ANDA)
ANDA 085447 · ABBOTT
- —A-POXIDEGeneric (ANDA)
ANDA 085517 · ABBOTT
- —A-POXIDEGeneric (ANDA)
ANDA 085518 · ABBOTT
- —A-POXIDEGeneric (ANDA)
ANDA 085513 · ABBOTT
- —CHLORDIAZACHELGeneric (ANDA)
ANDA 085086 · RACHELLE
- —CHLORDIAZACHELGeneric (ANDA)
ANDA 084639 · RACHELLE
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
